New england journal of medicine publishes positive phase 3 dupixent® (dupilumab) results in children with moderate-to-severe asthma

New england journal of medicine p ublishes p ositive phase 3 dupixent ® (dupilumab) results in children with moderate-to-severe asthma

REGN Ratings Summary

REGN Quant Ranking